Humanistic burden and medical care patterns of real-world patients with myasthenia gravis in Japan
Most patients in this Japanese cohort with gMG received maintenance therapy and the time from symptom onset to diagnosis was relatively short. However, impaired HRQoL remained.
Authors
- Clare Ringland
- Tom Webb (ORCID: https://orcid.org/0000-0002-4625-4052)
- Gregor Gibson
- Yosuke Saga (ORCID: https://orcid.org/0000-0002-9186-524X)
- Mami Kasahara‐Kiritani (ORCID: https://orcid.org/0000-0003-0170-1442)
- Niall Hatchell (ORCID: https://orcid.org/0000-0002-8432-6379)
- Keira Joann Herr (ORCID: https://orcid.org/0000-0003-1322-6407)
- Shiva Lauretta Birija
- Nan Li (ORCID: https://orcid.org/0000-0003-0509-3333)
- Dae Young Yu (ORCID: https://orcid.org/0000-0003-1091-5792)
- Sayuri Watanabe
- Joe Conyers
Institutions
- Johnson & Johnson (United States) (US)
- Adelphi Group (United Kingdom) (GB)
- Johnson & Johnson (Singapore) (SG)
- Johnson & Johnson (Brazil) (BR)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-12-11
- DOI
- https://doi.org/10.3389/fneur.2025.1673297
- Citations
- 1
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 1.39